Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Trendbericht Anorganik 2024: Hauptgruppen- und Molekülchemie

Journal article

Fischer M. and Heift D., (2024), Nachrichten aus der Chemie, 72, 46 - 57

Trendbericht Anorganische Chemie 2023: Hauptgruppen

Journal article

Heift D. and Fischer M., (2023), Nachrichten aus der Chemie, 71, 46 - 57

Gene therapy for inherited retinal disease: long-term durability of effect.

Journal article

Leroy BP. et al, (2022), Ophthalmic Res

Development of a functional assay for the assessment of two common CRB1 mutations

Conference paper

Bellingrath J-S. et al, (2022), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 63

Neural plasticity of the human visual system reflects treatment effect in gene therapy for Achromatopsia

Conference paper

Seitz IP. et al, (2022), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 63

PERCEIVE study report: Real-world safety and effectiveness of voretigene neparvovec

Conference paper

Fischer MD. et al, (2022), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 63

Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec.

Journal article

Reichel FF. et al, (2022), Br J Ophthalmol

Central Visual Function and Genotype-Phenotype Correlations in PDE6A-Associated Retinitis Pigmentosa.

Journal article

Kuehlewein L. et al, (2022), Invest Ophthalmol Vis Sci, 63

Kinetics of Heterogeneous Background in Stargardt's Disease over Time.

Journal article

Rodríguez-Bocanegra E. et al, (2022), Life (Basel), 12

[From Bench to Bedside: Challenges in the Development of Genetherapeutic Approaches].

Journal article

Priglinger C. and Fischer MD., (2022), Klin Monbl Augenheilkd, 239, 261 - 262

Benefits and Shortcomings of Laboratory Model Systems in the Development of Genetic Therapies.

Journal article

Bucher K. et al, (2022), Klin Monbl Augenheilkd, 239, 263 - 269

Load More